Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,850.00p
   
  • Change Today:
    -30.00p
  • 52 Week High: 2,544.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 32,346
  • Market Cap: £1,221.61m
  • RiskGrade: 128

Low demand for bull semen brings reduced profits for Genus

By Josh White

Date: Thursday 17 Nov 2016

LONDON (ShareCast) - (ShareCast News) - Bull semen and animal genetics specialist Genus published a trading update to coincide with its AGM on Thursday, covering the period from 1 July to 16 November.
The FTSE 250 firm said market conditions for its customers were mixed.

"Strong pig production volumes in some markets, such as the US, resulted in significantly reduced pig prices for producers there, but pig prices improved in Europe and remained strong in China, which supported continuing good demand for [our] PIC genetics and growth in volumes in the period," its board said in a statement.

"Dairy prices globally started to improve, but are still at levels where many dairy farmers are not profitable."

Genus said beef prices fell in the US throughout the year, resulting in a more cautious approach from customers.

"These market conditions, combined with increased price competition particularly in North and Latin America, resulted in lower semen volumes for Genus ABS, while IVB continued to grow embryo volumes."

Revenues for the four months to 31 October 2016 increased modestly in constant currency compared with the prior year, with increased porcine stockings and royalties largely offset by lower bovine semen sales, it reported.

"As expected, adjusted profit before tax was lower in constant currency as planned increases in research and development expenditure were made, while exchange rates provided a benefit during the period."

The board confirmed Saskia Korink, chief operating officer of Genus ABS Dairy, has left the company and Karim Bitar is leading the ABS Dairy business while a search for Korink's successor, which is underway, is concluded.

Genus said it continues to await judgement from the Federal Court in Wisconsin on its request for an injunction to enable it to terminate its Sexing Technologies semen sorting contract without penalty or damages.

"This would enable the early introduction of competition into the market for processing sexed bovine semen through the launch of our Genus Sexed Semen technology.

"Genus made progress towards its strategic objectives during the period under review and expects to perform in line with overall expectations for the financial year 2017."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,850.00p
Change Today -30.00p
% Change -1.60 %
52 Week High 2,544.00
52 Week Low 1,637.00
Volume 32,346
Shares Issued 66.03m
Market Cap £1,221.61m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.77% below the market average95.77% below the market average95.77% below the market average95.77% below the market average95.77% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
56.11% below the market average56.11% below the market average56.11% below the market average56.11% below the market average56.11% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Income
85.12% below the market average85.12% below the market average85.12% below the market average85.12% below the market average85.12% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.71% below the market average67.71% below the market average67.71% below the market average67.71% below the market average67.71% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 17-May-2024

Time Volume / Share Price
16:35 17,021 @ 1,850.00p
16:35 92 @ 1,850.00p
16:35 136 @ 1,850.00p
16:35 6 @ 1,850.00p
16:35 6 @ 1,850.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page